Pharming Group announces the filing of its 2022 Annual Report and Form 20-F
Financial updatesPharming Group N.V. announces the filing of its Annual Report for the year ended December 31, 2022 (the “Period”).
Pharming Group reports financial results for full year 2022
Financial updatesPharming Group N.V. presents its preliminary (unaudited) financial report for the full year ended December 31, 2022. Download the press release below.
Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank Limited in light of UK Government announcement
Financial updates
Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcement
Financial updates
Pharming Group issues statement regarding the events surrounding Silicon Valley Bank
Financial updatesPharming Group N.V. is aware that the Federal Deposit Insurance Corporation (“FDIC”) has been appointed receiver of Silicon Valley Bank (“SVB US”) and that the Bank of England, barring any intervening events, intends to put Silicon Valley Bank UK Limited (“SVB UK”) into insolvency.
Notice of Full Year 2022 financial results
Financial updatesPharming Group N.V. confirms it will announce its unaudited Full Year 2022 financial results for the year ended December 31, 2022, on Thursday, March 16, 2023.
Pharming Group reports earnings for the first nine months of 2022
Financial updatesPharming Group N.V. presents its preliminary, unaudited financial report for the first nine months ended September 30, 2022.
Pharming Group Notice of Q3 Results
Financial updatesPharming Group N.V. confirms it will announce financial results for the nine months ended September 30, 2022 on Thursday, October 27, 2022.
Pharming Group reports financial results for the first half of 2022
Financial updatesPharming Group N.V. presents its preliminary (unaudited) financial report for the first six months of 2022 ended June 30, 2022.
Pharming Group Notice of H1 2022 Results
Financial updatesPharming confirms it will announce financial results for the six months ended 30 June 2022 on Thursday, August 4, 2022.